Search

everythinglearnresearchcommunity

for

Search:↓

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Tofacitinib is an effective and safe treatment for alopecia areata.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Vitamin D3 helps treat mild to moderate alopecia areata, especially when combined with other treatments.

Intralesional methotrexate and triamcinolone acetonide are more effective than Vitamin D3 for treating alopecia areata.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Alefacept does not effectively treat severe alopecia areata.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Higher IL-37 levels are linked to more severe alopecia areata, but the gene variation doesn't affect disease risk.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Better documentation of alopecia areata in Black individuals is needed to improve diagnosis.

The treatment with Bakuchiol and Neem oil significantly improved hair growth and was well-received by most participants.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Tofacitinib effectively treats Alopecia Areata.